Dr. Michael Agadjanyan is Vice President, Professor and Head of the Department of Molecular Immunology at the Institute for Molecular Medicine (IMM), Huntington Beach, California, a non-profit scientific research organization focused on chronic human diseases, including neurodegenerative disorders. He has more than 20 years of experience in the central nervous system field and 47 years of experience […]

Four months after forging a collaboration to develop an experimental atopic dermatitis treatment, Amgen and Japan’s Kyowa Kirin are beginning to see the fruits of that deal with positive Phase II data for AMG 451/KHK4083, a potential first-in-class anti-OX40 monoclonal antibody. At a presentation at the 30th Annual European Academy of Dermatology and Venereology (EADV) Congress, Amgen and Kyowa Kirin showed that AMG 451/KHK4083 […]

DarioHealth (NSDQ:DRIO) announced that it launched Dario Move, a digital physical therapy platform for musculoskeletal (MSK) conditions. With the introduction of the Dario Move, Boston-based Dario adds to its suite of chronic condition management platforms that include treatments for diabetes, behavioral health and metabolic health, according to a news release.